How can the EDS help you identify patients at high risk of oesophageal cancer?

1st September 2021

The Edinburgh Dysphagia Score (EDS) can support the assessment of patients with dysphagia by identifying patients at lowest risk of a malignant diagnosis, thereby allowing resources to be concentrated on those at highest risk.

In the original study, the EDS identified a group of patients at the highest risk of cancer; in this group the cancer yield at endoscopy was approximately 17-20%. Calculating the EDS therefore enables patients most at risk to be prioritised for endoscopy.

It is recommended that healthcare professionals act on any clinical suspicion and their decision to refer a patient should not be based on the EDS alone.

Find out more:

  • Access GatewayC’s ‘Oesophageal Cancer – Early Diagnosis’ course here
  • Read Urgent Cancer Diagnostic Services During Covid19 document here
  • Read a guide to the Edinburgh Dysphagia Score document here
  • Read GatewayC’s ‘4 tips to manage Barrett’s Oesophagus’ blog here

LinkedIn | Twitter | Facebook

Latest from the Blog

Are lung metastases visible on a chest X-ray?

Are lung metastases visible on a chest X-ray?

28 July 2022 The lungs are the second most common site of secondary breast cancer and presenting symptoms of lung metastases can be vague. Common symptoms such as cough, chest pain and shortness of breath have many different causes. A chest X-ray is a useful...

read more

Related Posts

Are lung metastases visible on a chest X-ray?

Are lung metastases visible on a chest X-ray?

28 July 2022 The lungs are the second most common site of secondary breast cancer and presenting symptoms of lung metastases can be vague. Common symptoms such as cough, chest pain and shortness of breath have many different causes. A chest X-ray is a useful...

read more